AU2002210661A1 - Nucleic acid generating the ABCA7 gene, molecules modulating its activity and therapeutic applications - Google Patents

Nucleic acid generating the ABCA7 gene, molecules modulating its activity and therapeutic applications

Info

Publication number
AU2002210661A1
AU2002210661A1 AU2002210661A AU1066102A AU2002210661A1 AU 2002210661 A1 AU2002210661 A1 AU 2002210661A1 AU 2002210661 A AU2002210661 A AU 2002210661A AU 1066102 A AU1066102 A AU 1066102A AU 2002210661 A1 AU2002210661 A1 AU 2002210661A1
Authority
AU
Australia
Prior art keywords
activity
nucleic acid
therapeutic applications
acid generating
molecules modulating
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2002210661A
Inventor
Isabelle Arnould-Reguigne
Giovanna Chimini
Patrice Denefle
Nicolas Duverger
Jose Osorio Y Fortea
Catherine Prades
Marie-Francoise Rosier
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Institut National de la Sante et de la Recherche Medicale INSERM
Aventis Pharma SA
Original Assignee
Institut National de la Sante et de la Recherche Medicale INSERM
Aventis Pharma SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from FR0013649A external-priority patent/FR2822165B1/en
Application filed by Institut National de la Sante et de la Recherche Medicale INSERM, Aventis Pharma SA filed Critical Institut National de la Sante et de la Recherche Medicale INSERM
Publication of AU2002210661A1 publication Critical patent/AU2002210661A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2217/00—Genetically modified animals
    • A01K2217/05—Animals comprising random inserted nucleic acids (transgenic)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2830/00—Vector systems having a special element relevant for transcription
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2830/00—Vector systems having a special element relevant for transcription
    • C12N2830/80—Vector systems having a special element relevant for transcription from vertebrates
    • C12N2830/85—Vector systems having a special element relevant for transcription from vertebrates mammalian

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Zoology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Wood Science & Technology (AREA)
  • Biophysics (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Cell Biology (AREA)
  • Plant Pathology (AREA)
  • Pain & Pain Management (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Toxicology (AREA)
  • Rheumatology (AREA)
  • Physics & Mathematics (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
AU2002210661A 2000-10-24 2001-10-17 Nucleic acid generating the ABCA7 gene, molecules modulating its activity and therapeutic applications Abandoned AU2002210661A1 (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
FR0013649A FR2822165B1 (en) 2000-10-24 2000-10-24 NUCLEIC ACID REGULATING THE ABCA7 GENE, MOLECULES MODULATING ITS ACTIVITY AND THERAPEUTIC APPLICATIONS
FR00/13649 2000-10-24
US25314100P 2000-11-28 2000-11-28
US60/253,141 2000-11-28
PCT/FR2001/003219 WO2002034903A2 (en) 2000-10-24 2001-10-17 Nucleic acid generating the abca7 gene, molecules modulating its activity and therapeutic applications

Publications (1)

Publication Number Publication Date
AU2002210661A1 true AU2002210661A1 (en) 2002-05-06

Family

ID=26212696

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2002210661A Abandoned AU2002210661A1 (en) 2000-10-24 2001-10-17 Nucleic acid generating the ABCA7 gene, molecules modulating its activity and therapeutic applications

Country Status (5)

Country Link
EP (1) EP1334186A2 (en)
JP (1) JP2004512045A (en)
AU (1) AU2002210661A1 (en)
CA (1) CA2426294A1 (en)
WO (1) WO2002034903A2 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2548017C (en) * 2003-12-15 2009-12-08 Noab Biodiscoveries Inc. Materials and methods for analysis of atp-binding cassette transporter gene expression

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2004507202A (en) * 1999-03-31 2004-03-11 キュラジェン　コーポレイション Nucleic acid containing an open reading frame encoding a polypeptide; "ORFX"
FR2796808B1 (en) * 1999-07-30 2004-03-12 Inst Nat Sante Rech Med NEW APPLICATIONS OF ABCA TYPE CONVEYORS

Also Published As

Publication number Publication date
JP2004512045A (en) 2004-04-22
EP1334186A2 (en) 2003-08-13
CA2426294A1 (en) 2002-05-02
WO2002034903A3 (en) 2002-08-08
WO2002034903A2 (en) 2002-05-02

Similar Documents

Publication Publication Date Title
AU2002336367A1 (en) Adamts13 genes and proteins and variants, and uses thereof
AU6382100A (en) Parasitic helminth diag2 proteins, nucleic acid molecules, and uses thereof
AU4903101A (en) Isolated nucleic acid molecules encoding cancer associated antigens, the antigens per se, and uses thereof
AU3510200A (en) Human dickkopf-related protein and nucleic acid molecules and uses therefor
AU2002336288A1 (en) Weed controller metabolism proteins, genes thereof and use of the same
WO2000053776A3 (en) Human kallikrein-like genes
AU3354499A (en) Human mekk proteins, corresponding nucleic acid molecules, and uses therefor
AU2002243750A1 (en) Novel nucleic acid and polypeptide molecules
AU2002362800A1 (en) Modulation of the expression of genes dependent on stat-1
AU2001249929A1 (en) Fdrg proteins and nucleic acid molecules and uses therefor
AU2002210661A1 (en) Nucleic acid generating the ABCA7 gene, molecules modulating its activity and therapeutic applications
EP1177207A4 (en) Dna encoding the prostate-specific membrane antigen-like gene and uses thereof
AU2001290872A1 (en) Isolated human kinase proteins, nucleic acid molecules and uses thereof
AU2002323612A1 (en) Novel clark protein and nucleic acid molecules and uses therefor
AU2002258617A1 (en) Isolated human enzyme proteins, nucleic acid molecules encoding human enzyme proteins, and uses thereof
AU2002356494A1 (en) Isolated human enzyme proteins, nucleic acid molecules encoding human enzyme proteins, and uses thereof
AU2002254438A1 (en) Isolated human enzyme proteins, nucleic acid molecules encoding human enzyme proteins, and uses thereof
AU2002250346A1 (en) Isolated human enzyme proteins, nucleic acid molecules encoding human enzyme proteins, and uses thereof
MXPA03005428A (en) Novel glutamate receptor modulatory proteins and nucleic acid molecules and uses therefor.
AU2002257065A1 (en) Isolated human aminoacylase, nucleic acid molecules encoding human aminoacylase, and uses thereof
WO2003031639A8 (en) Isolated cryopyrins, nucleic acid molecules encoding these, and use thereof
AU2001227570A1 (en) Isolated nucleic acid molecules encoding cancer associated antigens, the antigens per se, and uses thereof
EP1383876A4 (en) Isolated human enzyme proteins, nucleic acid molecules encoding human enzyme proteins, and uses thereof
AU2002258582A1 (en) Human lanosterol synthase, nucleic acid molecules encoding the same, and uses thereof
AU2002239227A1 (en) Isolated human enzyme, nucleic acid molecules encoding human enzyme, and uses thereof

Legal Events

Date Code Title Description
MK5 Application lapsed section 142(2)(e) - patent request and compl. specification not accepted